LABORATORY CORP AMER HLDGS - NOTE 9/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2020

Type / Class
Debt / NOTE 9/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LABORATORY CORP AMER HLDGS - NOTE 9/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2020 Q1 $0 $0 -$926,407 0
2019 Q4 $47 $7,951 -$2,082,049 16917.02% 1
2019 Q3 $935,467 $3,008,456 +$918,456 225.57% 3
2019 Q2 $930,000 $2,156,000 231.78% 2
2019 Q1 $930,000 $1,907,000 +$119,186 205.03% 2
2018 Q4 $930,000 $1,563,000 -$17,959,220 168.0% 3
2018 Q3 $8,643,000 $20,116,000 -$812,920 232.76% 4
2018 Q2 $8,968,000 $21,659,000 241.51% 4
2018 Q1 $8,968,000 $19,513,000 217.17% 4
2017 Q4 $8,968,000 $19,247,000 -$4,967,598 214.34% 4
2017 Q3 $11,406,000 $23,197,000 -$995,713 203.31% 4
2017 Q2 $11,886,000 $24,646,000 -$29,259,378 207.49% 7
2017 Q1 $26,237,000 $50,329,000 -$34,110,820 191.31% 9
2016 Q4 $45,631,000 $78,474,000 -$14,735,701 171.91% 11
2016 Q3 $53,448,000 $98,401,000 -$39,438,203 184.31% 12
2016 Q2 $74,878,000 $130,476,000 -$11,623,231 174.43% 11
2016 Q1 $81,477,000 $127,817,000 -$5,041,590 156.95% 12
2015 Q4 $84,686,000 $140,641,000 -$4,315,434 166.01% 12
2015 Q3 $108,295,000 $154,860,000 -$39,358,848 145.45% 12
2015 Q2 $110,335,000 $179,982,000 +$32,672,907 162.56% 13
2015 Q1 $90,469,000 $153,189,000 -$27,905,385 169.11% 11
2014 Q4 $107,084,000 $155,194,000 +$34,930,103 144.68% 12
2014 Q3 $109,544,000 $149,284,000 -$913,107 136.3% 12
2014 Q2 $110,208,000 $151,316,000 -$13,781,904 137.2% 12
2014 Q1 $120,668,000 $159,337,000 -$6,917,203 131.7% 13